Stephen Hawking: Defying ALS and revolutionizing our understanding of the universe

Stephen Hawking is renowned not only for his groundbreaking contributions to theoretical physics but also for his extraordinary resilience in the face of a devastating diagnosis. His journey with amyotrophic lateral sclerosis (ALS) is as remarkable as his scientific achievements. Diagnosed with ALS at the age of 21, Hawking's journey provides profound insights into the lived experience of ALS.

ALS, also known as Lou Gehrig disease after the star baseball slugger who succumbed to the disease, is characterized by the progressive degeneration of motor neurons in the brain and spinal cord, leading to muscle weakness, atrophy, and eventual paralysis. The pathophysiology of ALS involves complex mechanisms, including oxidative stress, mitochondrial dysfunction, and abnormal protein aggregation. Despite extensive research, the precise etiology remains elusive, although genetic mutations such as SOD1, C9orf72, and TARDBP have been identified in familial cases.

In 1963, while a graduate student at the University of Cambridge, Hawking began experiencing early symptoms of ALS, such as muscle weakness and slurred speech. These initial manifestations rapidly progressed, leading to a diagnosis that came with a grim prognosis—2 years to live. For neurologists, this early phase highlights the importance of differential diagnosis and the challenges in prognostication for patients with ALS in whom clinical variability can be significant. Spinal muscular atrophy type 3 might have been considered as an alternate diagnosis. Genetic testing was not yet available at the time of his diagnosis, but, presumably, he had no family history of such a disorder. It is not publicly known whether he underwent genetic testing later in life. However, by then he had evolved upper motor neuron signs as well, leaving little doubt that he had ALS.

As ALS advanced, Hawking's motor functions continued to deteriorate. By the mid-1970s, he lost his ability to walk and eventually required a wheelchair. His upper limb function also declined, impacting his ability to write and feed himself. Despite these challenges, Hawking's intellectual faculties remained intact, a hallmark of ALS where cognitive functions are generally preserved. He continued to work, thanks in part to the support of his family, friends, and colleagues, as well as his own extraordinary willpower.

Hawking's most significant scientific contribution came in 1974 with his proposal of Hawking radiation, a groundbreaking theory that black holes emit radiation. This discovery bridged concepts from quantum mechanics and general relativity, challenging the previously held notion that nothing could escape from a black hole. This discovery not only cemented Hawking's place in the annals of science but also sparked new lines of inquiry into the nature of the universe.

In the realm of assistive technology, Hawking's journey is particularly illustrative. After a tracheostomy in 1985 rendered him unable to speak, he began using a speech-generating device controlled by a single cheek muscle. This technology enabled him to continue his scientific work and to communicate effectively, emphasizing the vital role of adaptive technologies in enhancing the quality of life for patients with ALS.

Throughout his life, Hawking remained an active public figure, authoring numerous books, including the best-selling "A Brief History of Time," and appearing in the popular media. His ability to explain complex scientific concepts in an accessible manner captivated millions and inspired a new generation of scientists and enthusiasts. For neurologists, his story is a powerful reminder of the potential for individuals with ALS to lead fulfilling, productive lives with the appropriate medical, technological, and emotional support.

He defied the odds, living for more than 50 years after his diagnosis, as he continued to push the boundaries of human knowledge. His lengthy survival should serve as a cautionary tale to neurologists who might be quick to discourage their patients with bad news. Stephen Hawking passed away on March 14, 2018 at the age of 76, but his legacy endures. Beyond his scientific discoveries, Hawking is a heroic figure who faced down one of the most devastating neurologic diseases, showing that sometimes even the most daunting challenges yield to hope, courage, and perseverance.

MedLink acknowledges the use of ChatGPT-4, an Artificial Intelligence chatbot, in drafting this blog entry.

Are you interested in being a guest blogger for MedLink Neurology? Contact us at editorial@medlink.com.